ATE404195T1 - Verwendung von phenylbenzamide-derivaten zur behandlung von chronisch-obstruktiver lungenerkrankung (copd) - Google Patents

Verwendung von phenylbenzamide-derivaten zur behandlung von chronisch-obstruktiver lungenerkrankung (copd)

Info

Publication number
ATE404195T1
ATE404195T1 AT04019648T AT04019648T ATE404195T1 AT E404195 T1 ATE404195 T1 AT E404195T1 AT 04019648 T AT04019648 T AT 04019648T AT 04019648 T AT04019648 T AT 04019648T AT E404195 T1 ATE404195 T1 AT E404195T1
Authority
AT
Austria
Prior art keywords
hydrogen
copd
chronic obstructive
group
lung disease
Prior art date
Application number
AT04019648T
Other languages
English (en)
Inventor
Lucio Rovati
Antonio Giordani
Gianfranco Caselli
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Application granted granted Critical
Publication of ATE404195T1 publication Critical patent/ATE404195T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04019648T 2004-08-19 2004-08-19 Verwendung von phenylbenzamide-derivaten zur behandlung von chronisch-obstruktiver lungenerkrankung (copd) ATE404195T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04019648A EP1634595B1 (de) 2004-08-19 2004-08-19 Verwendung von Phenylbenzamide-derivaten zur Behandlung von chronisch-obstruktiver Lungenerkrankung (COPD)

Publications (1)

Publication Number Publication Date
ATE404195T1 true ATE404195T1 (de) 2008-08-15

Family

ID=34926220

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04019648T ATE404195T1 (de) 2004-08-19 2004-08-19 Verwendung von phenylbenzamide-derivaten zur behandlung von chronisch-obstruktiver lungenerkrankung (copd)

Country Status (12)

Country Link
US (1) US7482371B2 (de)
EP (1) EP1634595B1 (de)
JP (1) JP4987268B2 (de)
AT (1) ATE404195T1 (de)
AU (1) AU2005203706B2 (de)
CA (1) CA2514373C (de)
DE (1) DE602004015788D1 (de)
DK (1) DK1634595T3 (de)
ES (1) ES2311771T3 (de)
PL (1) PL1634595T3 (de)
PT (1) PT1634595E (de)
SI (1) SI1634595T1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2635649A1 (en) * 2006-01-06 2007-07-12 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and andolast
EP1845093B1 (de) 2006-04-10 2009-06-10 Rottapharm S.p.A. Neue kristalline und stabile Form von Andolast
PT2054057E (pt) 2006-07-31 2011-05-05 Rottapharm Spa Combina??o de andolast/glucocortic?ides
JP5459827B2 (ja) 2009-03-13 2014-04-02 株式会社Ｌｔｔバイオファーマ 慢性閉塞性肺疾患改善剤
WO2012035122A1 (en) 2010-09-17 2012-03-22 Dundalk Institute Of Technology Anthraquinone compounds and their uses
EP2439200A1 (de) * 2010-09-17 2012-04-11 Dundalk Institute of Technology Anthrachinon-Verbindungen und deren Verwendungen
WO2013137009A1 (ja) 2012-03-14 2013-09-19 株式会社Ｌｔｔバイオファーマ 慢性閉塞性肺疾患改善剤
JPWO2015122031A1 (ja) 2014-02-17 2017-03-30 株式会社Ｌｔｔバイオファーマ メペンゾラート光学活性体及びそれを有効成分とする慢性閉塞性肺疾患改善剤
CA2976889C (en) 2015-03-02 2023-06-27 Ltt Bio-Pharma Co., Ltd. Quinuclidine derivative

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1232252B (it) * 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
PT896821E (pt) 1997-08-08 2003-08-29 Rotta Research Lab Uma nova composicao farmaceutica para inalacao que contem cr 2039 (andolast)
AU2159300A (en) 1998-12-08 2000-06-26 Nutramax Laboratories, Inc. Combinations of st. john's wort and fatty acids
AU5390900A (en) * 1999-06-29 2001-01-22 Neurosearch A/S Potassium channel blocking agents
IL158776A0 (en) * 2001-05-25 2004-05-12 Pfizer A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
JP2005533814A (ja) * 2002-06-26 2005-11-10 ポセイドン・ファーマスーティカルス・アクティーゼルスカブ 新規ベンズイミダゾール−２−オン誘導体及びその使用方法
CA2570386A1 (en) * 2004-06-14 2005-12-29 Sepracor Inc. Methods of using albuterol and calcium activated potassium channel openers

Also Published As

Publication number Publication date
EP1634595B1 (de) 2008-08-13
AU2005203706B2 (en) 2011-04-14
US20060052427A1 (en) 2006-03-09
AU2005203706A1 (en) 2006-03-09
US7482371B2 (en) 2009-01-27
ES2311771T3 (es) 2009-02-16
JP2006056890A (ja) 2006-03-02
JP4987268B2 (ja) 2012-07-25
CA2514373C (en) 2012-07-10
CA2514373A1 (en) 2006-02-19
DE602004015788D1 (de) 2008-09-25
PL1634595T3 (pl) 2009-01-30
EP1634595A1 (de) 2006-03-15
DK1634595T3 (da) 2008-11-24
PT1634595E (pt) 2008-08-28
SI1634595T1 (sl) 2008-12-31

Similar Documents

Publication Publication Date Title
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
ATE517882T1 (de) Chinolinderivate
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
UA102517C2 (ru) Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы
NO20052802L (no) Pyrrolopyrimidinderivativer
CL2008001898A1 (es) Compuestos derivados de pirazinona, inhibidores de p38; proceso de preparacion de estos; composicion farmaceutica que los comprende; combinacion farmaceutica que los comprende; uso para tratar enferemedades pulmonares obstructivas cronicas y asma.
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
NO20073465L (no) Benzotiazol-derivater
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
CY1109734T1 (el) Ενωσεις για τη θεραπευτικη αντιμετωπιση της σχιζοφρενειας και/ή διαταραχων της ρυθμισης της γλυκοζης
EA200802329A1 (ru) Производные триазола ii
NZ515282A (en) Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
WO2009120660A3 (en) Substituted pyridoxazines
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
MX2008016134A (es) Derivados de fenol para el tratamiento de enfermedades respiratorias.
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
EA200802173A1 (ru) Производные терфенила для лечения болезни альцгеймера
NO20083058L (no) Cykloheksylsulfonamidderivater med H3 reseptor aktivitet
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
ATE404195T1 (de) Verwendung von phenylbenzamide-derivaten zur behandlung von chronisch-obstruktiver lungenerkrankung (copd)
ATE492534T1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
TW200716547A (en) Piperidin-4-yl-amide derivatives
NO20074622L (no) Metabolitter for NK-1 antagonister for brekninger
WO2007009723A3 (en) Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1634595

Country of ref document: EP

REN Ceased due to non-payment of the annual fee